Repurpose
Use an existing drug for a new indication.
DOING WELL BY DOING GOOD
Drug Discovery and Development with LADR
Innovative Accelerated Drug Development
Ladrion Therapeutics advances affordable, patent-protected therapies by improving known drugs through the LADR Smart Drug Development Platform.
Innovative Accelerated Drug Development
Accelerating New Drug Product Development.
Ladrion Therapeutics is focused on transforming healthcare through innovative drug development. The LADR Smart Drug Development Platform enables rapid advancement of new therapies by modifying existing drugs to create novel, patent-protected treatments at a fraction of traditional time, cost, and risk - expanding access across both high-income and lower-resourced nations.
Accelerating new drug product development. Therapies for many illnesses already exist. Ladrion Therapeutics identifies and develops them through a smarter, more efficient path.
The Four Pillars of LADR
Reprofile
Create better dosing or pediatric formulations to improve tolerance and efficacy.
Reposition
Modify a drug to overcome barriers such as solubility so it works better, including changing route of dosing.
Rescue
Revive assets that were failing due to absorption or tolerability limitations through chemical modification.
Impact, Platform & Partnership
Impact & DEI
United Nations Sustainable Development Goal 3
Aligned to United Nations SDG 3: Good Health and Well-Being - advancing safe, affordable medicines and vaccines while supporting resilient health systems.
LADR Platform
Revolutionary Smart Drug Development Technology
LADR - Ligand-Aided Drug Repurposing, Reprofiling, Repositioning and Rescue - is a proprietary methodology to improve drug products by chemically modifying approved drug substances to create new, patentable New Chemical Entities.
Partnership Focus
Innovative Pharmaceutical and Biotech Companies
With the LADR platform, we partner with innovative pharmaceutical and biotech companies, mission-driven foundations, and impact-focused investors to address unmet medical needs and improve quality of life for patients worldwide.
Key Advantages
01
4x Faster
Develop approximately 4x faster as compared to de novo drug development.
02
~5% Cost
~5% of cost as compared to de novo drug development.
03
Higher Success
Higher probability of success as compared to de novo drug development.
04
Patentable NCEs
Chemical modification creates patentable New Chemical Entities while avoiding the 10-12 year, $1-3B 505(b)(1) path.
Join Our Network of Strategic Partners
We are actively seeking collaborations that accelerate affordable, novel therapies for unmet medical needs.